Case Type: Mergers & Acquisitions

Logility Supply Chain Solutions, Inc. (Nasdaq: LGTY), relating to the proposed merger with Aptean. Under the terms of the agreement, Aptean will acquire all of Logility’s outstanding common stock for $14.30 per share in an all-cash transaction.

Redwire Corporation (NYSE: RDW), relating to the proposed merger with Edge Autonomy Ultimate Holdings, LP. Under the terms of the agreement, Redwire will acquire Edge Autonomy using $150M in cash and $775M in shares of Redwire common stock.

180 Degree Capital Corp. (Nasdaq: TURN), relating to the proposed merger with Mount Logan Capital Inc. Under the terms of the agreement, the estimated post-merger shareholder ownership would be approximately 40% for current 180 Degree Capital shareholders.

Amplify Energy Corp. (NYSE: AMPY), relating to the proposed merger with Juniper Capital. Under the terms of the agreement, Amplify shareholders will retain approximately 61% of Amplify’s outstanding equity.

ReShape Lifesciences Inc. (Nasdaq: RSLS), relating to the proposed merger with Vyome Therapeutics, Inc. Under the terms of the agreement, ReShape and Vyome will combine in an all-stock transaction, with ReShape stockholders owning approximately 11.1% of the combined company.

Edible Garden AG Incorporated (Nasdaq: EDBL), relating to the proposed merger with Narayan d.o.o. Under the terms of the non-binding letter of intent, in consideration for 100% of the share capital of Narayan, Edible Garden will issue to the Narayan shareholders shares of Edible Garden common stock.

Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), relating to the proposed merger with Decoy Therapeutics, Inc. Under the terms of the agreement, Salarius stockholders would own approximately 14% of the outstanding shares of the combined company.

H&E Equipment Services, Inc. (Nasdaq: HEES), relating to the proposed merger with Herc Holdings Inc. Under the terms of the agreement, H&E shareholders will receive $78.75 in cash and 0.1287 shares of Herc common stock for each share they own. H&E’s shareholders will own approximately 14.1% of the combined company.

Enfusion, Inc. (NYSE: ENFN), relating to the proposed merger with Clearwater Analytics. Under the terms of the agreement, Enfusion shareholders will receive $5.85 per share in cash and $5.40 per share in Clearwater Class A Common Stock.

Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), relating to the proposed merger with Johnson & Johnson. Under the terms of the agreement, Johnson & Johnson will acquire all outstanding shares of Intra-Cellular Therapies for a payment of $132.00 per share in cash.